The vasorelaxant effect of simvastatin in isolated aorta from diabetic rats
Open Access
- 1 March 2016
- journal article
- Vol. 12 (2) , 104-108
Abstract
The increasing incidence of diabetes mellitus (DM) is of great clinical significance. In this study, we aimed to investigate whether exposure of endothelium-intact aortic rings to simvastatin could have a vasorelaxant effect in diabetic rats. For induction of diabetes, streptozotocin (STZ) (60 mg/kg, i.p., single dose) was used. After 1 month, the cumulative reaction of isolated endothelium-intact aortic rings was determined to KCl and phenylephrine (PE) in the absence and presence of nitric oxide (NO) synthase inhibitor, i.e., nitro-L-arginine-methyl ester (L-NAME), and prostaglandin synthesis inhibitor, i.e., indomethacin. Meanwhile, the role of extracellular calcium was assessed in this respect. At the end of the study, the addition of simvastatin (at a concentration ≥ 10−5 M) caused a significant concentration-dependent relaxation response of PE-precontracted aortic rings for both control and diabetic groups (at a significant difference of P < 0.050), and this difference did not exist for KCl-precontracted aortic rings. Furthermore, both L-NAME (100 µM) and indomethacin (10 µM) significantly diminished the vasorelaxant response following simvastatin addition. Meanwhile, there was no statistically significant difference between control and diabetic groups in the absence of extracellular calcium. The results of this study suggest that simvastatin is able to relax PE-precontracted aortic rings isolated from STZ-diabetic rats via modulation of NO- and prostaglandin-dependent signaling and its effect is not via modulation of calcium mobilization from intracellular stores.Keywords
This publication has 13 references indexed in Scilit:
- Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin systemLife Sciences, 2014
- Effects of Atorvastatin and Insulin in Vascular Dysfunction Associated With Type 2 DiabetesPhysiological Research, 2014
- Quantitative imaging biomarkers for the evaluation of cardiovascular complications in type 2 diabetes mellitusJournal of Diabetes and its Complications, 2014
- Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complicationsClinical Science, 2013
- Lipid control in patients with coronary heart disease treated in primary care or cardiology clinicsJournal of Clinical Lipidology, 2013
- Acute Simvastatin Inhibits KATP Channels of Porcine Coronary Artery MyocytesPLOS ONE, 2013
- The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitusIndian Journal of Endocrinology and Metabolism, 2013
- Liver-Protective Effects of Hydroalcoholic Extract of Allium Hirtifolium Boiss. in Rats with Alloxan-Induced Diabetes Mellitus2010
- Simvastatin Reduces Expression and Activity of Lipoprotein-Associated Phospholipase A2 in the Aorta of Hypercholesterolaemic Atherosclerotic RabbitsJournal of International Medical Research, 2009
- Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the ratBritish Journal of Pharmacology, 2000